AGRN promotes lung adenocarcinoma progression by activating Notch signaling pathway and acts as a therapeutic target

AGRN promotes lung adenocarcinoma progression by activating Notch signaling pathway and acts as a therapeutic target

Lung cancer is the main reason for cancer-associated death globally, and lung adenocarcinoma (LUAD) is the most prevalent subtype of lung cancer. Recently, AGRN is considered playing an vital role in the development of some cancers. However, the regulatory effects and mechanisms of AGRN in LUAD rema...

Full description

Bibliographic Details
Main Authors: Huan Zhang, Jiaqi Liang, Tao Lu, Ming Li, Guangyao Shan, Guoshu Bi, Mengnan Zhao, Xing Jin, Qun Wang, Zhengcong Chen, Cheng Zhan
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Pharmacological Research
Subjects:
Lung adenocarcinoma
AGRN
Prognosis
Proliferation
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661823001755

Internet

http://www.sciencedirect.com/science/article/pii/S1043661823001755

Similar Items